Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic

被引:2
|
作者
Ali, Amjad [1 ]
Waqar, Muhammad [2 ,3 ]
Akram, Ayesha [4 ]
Rafique, Shazia [5 ]
Rehman, Gauhar [6 ]
Idrees, Muhammad [2 ,5 ,7 ]
Halim, Sobia Ahsan [8 ]
Waqas, Muhammad [1 ,8 ]
Uddin, Jalal [9 ]
Gojayev, Anar [10 ]
Khan, Ajmal [8 ]
Al-Harrasi, Ahmed [8 ]
机构
[1] Hazara Univ Mansehra, Dept Biotechnol & Genet Engn, Khyber Pakhtunkhwa, Pakistan
[2] Genome Ctr Mol Based Diagnost & Res GCMBDR Lahore, Lahore, Pakistan
[3] Quaid E Azam Univ Islamabad, Dept Biotechnol, Islamabad, Pakistan
[4] Univ Punjab, Mol Virol Lab Ctr Appl Mol Biol CAMB, 87-West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan
[5] Univ Punjab, Ctr Excellence Mol Biol CEMB, Div Mol Virol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan
[6] Category D Hosp Talash Dir Lower, Malakand Div, Khyber Pakhtunkhwa, Pakistan
[7] Univ Peshawar, Khyber Pakhtunkhwa, Pakistan
[8] Univ Nizwa, Nat & Med Sci Res Ctr, Birkat Al Mou 616,POB 33, Nizwa, Oman
[9] King Khalid Univ, Coll Pharm, Dept Pharmaceut Chem, Abha 62529, Saudi Arabia
[10] ADA Univ, Sch Educ, Gen Educ Program, Ahmadbey Aghaoghlu str 11, AZ-1008 Baku, Azerbaijan
关键词
Seroepidemiology; SARS-CoV-2; IgG; Antibodies; Malakand; Pakistan; CORONAVIRUS;
D O I
10.1016/j.jiph.2023.05.036
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan.Materials & method: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA.Results: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer.Conclusion: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated.& COPY; 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1256 / 1261
页数:6
相关论文
共 50 条
  • [41] Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
    Alharbi, Naif Khalaf
    Alghnam, Suliman
    Algaissi, Abdullah
    Albalawi, Hind
    Alenazi, Mohammed W.
    Albargawi, Areeb M.
    Alharbi, Abdullah G.
    Alhazmi, Abdulaziz
    Al Qarni, Ali
    Alfarhan, Ali
    Zowawi, Hosam M.
    Alhatmi, Hind
    Alghamdi, Jahad
    Alroqi, Fayhan
    Batarfi, Khalid
    Arabi, Yaseen M.
    Hashem, Anwar M.
    Bosaeed, Mohammed
    Aldibasi, Omar
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (07) : 832 - 838
  • [42] Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran
    Seyed Abbas Mousavi
    Hamed Rouhanizadeh
    Majid Saeedi
    Mahmood Moosazadeh
    Abolqasem Ajami
    Afsaneh Fendereski
    Jamshid Yazdani-Charati
    Seyed Mohsen Soleimani
    Nader Ahangar
    Seyed Hossein Seyedpour
    Zahra Bandalizaeh
    Asian Pacific Journal of Tropical Medicine, 2021, 14 (01) : 10 - 16
  • [43] SEROPREVALENCE OF SARS-CoV-2 IN AUSTRALIAN BLOOD DONORS
    Hirani, Rena
    Machalek, Dorothy
    Vette, Kaitlyn
    Gidding, Heather
    Shilling, Hannah
    Nicholson, Suellen
    O'Sullivan, Matthew
    Dwyer, Dominic
    McCartney, Kristine
    Kaldor, John
    Gosbell, Iain
    Downes, Marnie
    Carlin, John
    Irving, David O.
    INTERNAL MEDICINE JOURNAL, 2021, 51
  • [44] Seroprevalence of SARS-CoV-2 in Hong Kong returnees
    Hanage, William P.
    Vincent, Victor I.
    Low, Nicola M.
    LANCET MICROBE, 2020, 1 (04): : E147 - E147
  • [45] Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
    Dong, Qunfeng
    Gao, Xiang
    JAMIA OPEN, 2020, 3 (04) : 496 - 499
  • [46] Potential drawbacks of SARS-CoV-2 seroprevalence surveys
    Lippi, G.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 206 - 206
  • [47] Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait
    Alali, Walid Q.
    Bastaki, Hamad
    Longenecker, Joseph C.
    Aljunid, Syed Mohamed
    AlSeaidan, Mohammad
    Chehadeh, Wassim
    Vainio, Harri
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (02)
  • [48] Update on SARS-CoV-2 seroprevalence: regional and worldwide
    Rostami, Ali
    Sepidarkish, Mahdi
    Fazlzadeh, Aylar
    Mokdad, Ali H.
    Sattarnezhad, Aida
    Esfandyari, Sahar
    Riahi, Seyed Mohammad
    Mollalo, Abolfazl
    Dooki, Mohammadreza Esmaeili
    Bayani, Masomeh
    Nazemipour, Maryam
    Mansournia, Mohammad Ali
    Hotez, Peter J.
    Gasser, Robin B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1762 - 1771
  • [49] Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
    Roarty, Cathal
    Tonry, Claire
    McFetridge, Lisa
    Mitchell, Hannah
    Watson, Chris
    Waterfield, Thomas
    LANCET INFECTIOUS DISEASES, 2021, 21 (06): : E143 - E143
  • [50] Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran
    Mousavi, Seyed
    Rouhanizadeh, Hamed
    Saeedi, Majid
    Moosazadeh, Mahmood
    Ajami, Abolqasem
    Fendereski, Afsaneh
    Yazdani-Charati, Jamshid
    Soleimani, Seyed
    Ahangar, Nader
    Seyedpour, Seyed
    Bandalizaeh, Zahra
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2021, 14 (01) : 10 - 16